EZ-482 |
Catalog No.GC60158 |
EZ-482, un nouveau ligand de l'apolipoprotéine (apoE), se lie aux sites de l'apoE dans le domaine C-terminal avec un Kd de 5 À 10 μM pour l'apoE3 et l'apoE4.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1016456-76-0
Sample solution is provided at 25 µL, 10mM.
EZ-482, a novel ligand of apolipoprotein (apoE), binds to sites on apoE in the C-terminal domain with Kds of 5-10 μM for apoE3 and apoE4. EZ-482 binds to apoE4 by a unique N-terminal allosteric effect. EZ482 has the potential for Alzheimer's diseas[1].
EZ-482 binds to sites on apoE in the C-terminal domain encompassing residues 229-243 and 258-265[1]. EZ-482 (0.5, 1, 5, 10 μM; 1 hour) blocks heparin binding in a concentration-dependent manner[1].
[1]. Tridib Mondal, et al. ApoE: In Vitro Studies of a Small Molecule Effector. Biochemistry. 2016 May 10;55(18):2613-21.
Average Rating: 5
(Based on Reviews and 21 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *